You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ad26.COV2.S

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronavirus Disease Trial in United States (Ad26.COV2.S)

Completed
Has Results
  • Coronavirus Disease
  • Ad26.COV2.S
  • Phoenix, Arizona
  • +20 more
Jan 17, 2023

Kidney Transplant Recipient Trial in Phoenix, Jacksonville, Rochester (Janssen Ad26.CoV2.S Vaccine, Reduction in

Recruiting
  • Kidney Transplant Recipient
  • Janssen Ad26.CoV2.S Vaccine
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jul 14, 2022

SARS-CoV-2 Infection Trial in Bangkok (Full dose of Ad26.COV2. 5x10^10vp, Half dose of Ad26.COV2. 2.5x10^10vp)

Recruiting
  • SARS-CoV-2 Infection
  • Full dose of Ad26.COV2. 5x10^10vp
  • Half dose of Ad26.COV2. 2.5x10^10vp
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Sep 11, 2022

COVID-19, Vaccine Reaction, SARS CoV 2 Infection Trial in Bamako (Ad26.COV2.S, NVX-CoV2373)

Not yet recruiting
  • COVID-19
  • +3 more
  • Ad26.COV2.S
  • NVX-CoV2373
  • Bamako, Mali
    CVD-MALI
Jun 7, 2022

Healthy Trial in Groningen (Ad26.COV2.S)

Completed
  • Healthy
  • Ad26.COV2.S
  • Groningen, Netherlands
    PRA Health Sciences
Dec 21, 2021

Healthy Trial in Worldwide (Ad26.COV2.S, Placebo)

Completed
  • Healthy
  • Ad26.COV2.S
  • Placebo
  • Berlin, Germany
  • +12 more
May 3, 2022

Coronavirus Disease-2019 (COVID-19) Prevention Trial in Worldwide (Ad26.COV2.S)

Active, not recruiting
  • Coronavirus Disease-2019 (COVID-19) Prevention
  • Ad26.COV2.S
  • Buenos Aires, Argentina
  • +17 more
Jan 17, 2023

Healthy Trial in Fukuoka-shi, Fukuoka (Ad26.COV2.S, Placebo)

Completed
  • Healthy
  • Ad26.COV2.S
  • Placebo
  • Fukuoka-shi, Japan
  • +2 more
Nov 23, 2021

Sars-CoV-2 Infection Trial in South Africa (Alveavax-v1.2, Janssen Ad26.COV2.S)

Completed
  • Sars-CoV-2 Infection
  • Bloemfontein, Free State, South Africa
  • +7 more
May 2, 2023

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Not yet recruiting
  • Covid-19 Pandemics
  • Tuberculosis
  • Pfizer-BioNTech COVID-19 vaccine
  • +2 more
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

Oncology Patients to Novel Coronavirus Vaccines (IROC)

Recruiting
  • Cancer
  • COVID-19 Vaccination
  • Carmel, Indiana
  • +1 more
Aug 2, 2022

Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,

Recruiting
  • COVID-19
  • ChAdOx1 nCOV-19 vaccine (Vaxzeria)
  • +3 more
  • São Paulo, Brazil
    Techtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023

Covid-19 Prevention Trial in Belgium, United States (Ad26.COV2.S, Placebo)

Active, not recruiting
  • Covid-19 Prevention
  • Ad26.COV2.S
  • Placebo
  • San Diego, California
  • +11 more
Mar 15, 2022

Transverse Myelitis Related to SARS-CoV-2 Vaccines

Completed
  • Vaccine Adverse Reaction
  • SARS-CoV-2 vaccines
  • Caen, Basse Normandie, France
    Alexandre Joachim
Jan 3, 2022

Covid19 Trial in Maputo (BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell), Ad26.COV2.S (Recombinant,

Recruiting
  • Covid19
  • BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell)
  • +2 more
  • Maputo, Mozambique
    Centro de Investigação e Treino em Saúde da Polana Caniço - Inst
Mar 31, 2022

Covid19, Kidney Diseases, Vaccine Response Impaired Trial in Netherlands (mRNA-1273, Ad26.COV2.S vaccine)

Completed
  • Covid19
  • +3 more
  • mRNA-1273
  • Ad26.COV2.S vaccine
  • Nijmegen, Gelderland, Netherlands
  • +3 more
Mar 14, 2022

COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

Recruiting
  • COVID-19 Prevention
  • Ad26.COV2.S
  • Birmingham, Alabama
  • +48 more
Aug 2, 2022

COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)

Recruiting
  • COVID-19
  • Ad26.COV2.S
  • +4 more
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022

COVID-19 Trial in South Africa (Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer))

Recruiting
  • COVID-19
  • Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer)
  • Pretoria, Gauteng, South Africa
  • +4 more
Aug 23, 2022

COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

Recruiting
  • COVID-19 Prevention
  • Ad26.COV2.S
  • Little Rock, Arkansas
  • +54 more
Aug 2, 2022

Vaccine Responsiveness in Chronic Lymphocytic Leukemia

Active, not recruiting
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • PCV13 vaccine and any of the FDA-approved COVID-19 vaccine products (BNT162b2, mRNA-1273, or Ad26.COV2.S) based on local availability.
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Sep 20, 2021

Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 Trial in Worldwide

Active, not recruiting
  • Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19
  • Ad26.COV2.S
  • Placebo
  • Vestavia Hills, Alabama
  • +125 more
Jan 17, 2023

SARS (Severe Acute Respiratory Syndrome) Trial in South Africa (To monitor the effectiveness of the single dose Ad26.COV2.S

Completed
  • SARS (Severe Acute Respiratory Syndrome)
  • To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine
  • Mthatha, Eastern Cape, South Africa
  • +30 more
Jul 29, 2022

Healthy Volunteers Trial in France (COVID-19 Vaccine Janssen (Ad26.COV2-S))

Recruiting
  • Healthy Volunteers
  • COVID-19 Vaccine Janssen (Ad26.COV2-S)
  • Dijon, France
  • +9 more
Apr 21, 2022

COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)

Active, not recruiting
  • COVID-19
  • Vienna, Austria
    Medicial University of Vienna
Apr 12, 2022